Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MGEA5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BUD31 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
XPO1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
HERC4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CCT8 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
HIF1A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARMCX3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PTP4A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
HAX1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CAPZA2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMEM167A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TM2D2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
UBE2B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
AZI2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
IGBP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SELK - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SFXN1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PET117 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ORC4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RAB3GAP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on